SCHEMBL23924574

SCHEMBL23924574

CC(N)CC(C)CC(C)[C]=O

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL803810 0.78 ALDH1A1 (0.60) ALDH1A1TSHRMAPK1
SCHEMBL13400316 0.74 ALDH1A1 (0.56) ALDH1A1TSHRMAPK1
SCHEMBL4067490 0.74
SCHEMBL7544130 0.74
SCHEMBL18007386 0.69 TSHR (0.69) ALDH1A1TSHRMAPK1
SCHEMBL3360137 0.69 TSHR (0.69) ALDH1A1TSHRMAPK1
SCHEMBL270873 0.69
SCHEMBL27337101 0.67 TSHR (0.65) ALDH1A1TSHRMAPK1
SCHEMBL6133075 0.67
SCHEMBL13829657 0.65 ALDH1A1 (0.45) ALDH1A1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844775-B2 Method of treating fatty acid oxidation disorders using Omega3/Omega6 unsaturated or branched chain fatty acids University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2023-12-19 US claimed
US-20210353581-A1 Method of Treating Fatty Acid Oxidation Disorders Using Omega3/Omega6 Unsaturated or Branched Chain Fatty Acids UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2021-11-18 US claimed
US-20210322357-A1 Method of Treating Fatty Acid Oxidation Disorders Using Omega3/Omega6 Unsaturated or Branched Chain Fatty Acids UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2021-10-21 US claimed
WO-2024030367-A2 FATTY ACID-D-AMINO ACID PEPTIDES CONJUGATES AS ANAPLEROTIC COMPOUNDS FOR USE IN TREATING PROPIONIC ACIDEMIA, METHYLMALONIC ACIDURIAS, AND ENERGY METABOLIC DISORDERS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2024-02-08 WO disclosed
US-11844775-B2 Method of treating fatty acid oxidation disorders using Omega3/Omega6 unsaturated or branched chain fatty acids University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2023-12-19 US disclosed
US-20210353581-A1 Method of Treating Fatty Acid Oxidation Disorders Using Omega3/Omega6 Unsaturated or Branched Chain Fatty Acids UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2021-11-18 US disclosed
US-20210322357-A1 Method of Treating Fatty Acid Oxidation Disorders Using Omega3/Omega6 Unsaturated or Branched Chain Fatty Acids UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353581-A1 Method of Treating Fatty Acid Oxidation Disorders Using Omega3/Omega6 Unsaturated or Branched Chain Fatty Acids ELOVL6, ELOVL3, CPT1B ALDH1A1 660/4885TSHR 3413/4885MAPK1 4616/4885
US-11844775-B2 Method of treating fatty acid oxidation disorders using Omega3/Omega6 unsaturated or branched chain fatty acids ELOVL6, ELOVL3, CPT1B ALDH1A1 637/4885TSHR 3440/4885MAPK1 4635/4885
US-20210322357-A1 Method of Treating Fatty Acid Oxidation Disorders Using Omega3/Omega6 Unsaturated or Branched Chain Fatty Acids ELOVL6, ELOVL3, CPT1B ALDH1A1 637/4885TSHR 3440/4885MAPK1 4635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.